French medtech entrepreneurialism needs infrastructural back-up
This article was originally published in Clinica
Executive Summary
France does not lack innovative capacity in medical devices, but the infrastructures to support SMEs and start-ups need to be improved. That is the view of Odile Corbin, head of French medtech industry association Snitem. On a recent Snitem press trip to local innovators SuperSonic Imagine and Ekkyo, the consensus was that medtech companies need more help in clearing the increasingly high regulatory hurdles and also in gaining access to funding in France’s new healthcare landscape. IBI Informa principal analyst Ashley Yeo reports
You may also be interested in...
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.
An Ecosystem For Medtech Funding And Innovation Support – BioWales 2024
Creo Medical and Clinithink are among the healthtech innovators who have benefited from funding and advisory support offered by the Development Bank of Wales. All three gave a take on the current funding environment at BioWales in London 2024.